Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan PK in Pediatric HSCT
NCT04937634Phase 1Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of melphalan in hematopoietic stem cell transplantation (HSCT), sponsored by Seoul National University Hospital. Primary endpoint: Melphalan concentration. Status: unknown.
02
Drugs
melphalan
03
Conditions
hematopoietic stem cell transplantation (HSCT)
Beyond the preview
Go deeper on NCT04937634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937634.